Global Vaccine Adjuvants Market 2017 by Manufacturers, Countries, Type and Application, Forecast to 2022

Healthcare

This report focuses on the Vaccine Adjuvants in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa.

  • “An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

    Scope of the Report:
    This report focuses on the Vaccine Adjuvants in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

    Market Segment by Manufacturers, this report covers
    SEPPIC
    SDA BIO
    Brenntag Biosector
    SPI Pharma
    MVP Laboratories
    Tj Kaiwei
    Novavax
    Zhuoyue
    Aphios
    GSK
    CSL Limited
    Brenntag Biosector
    SEPPIC
    SPI Pharma
    Novavax
    Avanti Polar Lipids
    Aphios

    Market Segment by Regions, regional analysis covers
    North America (USA, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Columbia etc.)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

    Market Segment by Type, covers
    Oral
    Subcutaneous
    Intramuscular
    Others

    Market Segment by Applications, can be divided into
    Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
    Human Vaccine Adjuvants (Research Applications, Commercial Applications)

    There are 15 Chapters to deeply display the global Vaccine Adjuvants market.

    Chapter 1, to describe Vaccine Adjuvants Introduction, product scope, market overview, market opportunities, market risk, market driving force;

    Chapter 2, to analyze the top manufacturers of Vaccine Adjuvants, with sales, revenue, and price of Vaccine Adjuvants, in 2016 and 2017;

    Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

    Chapter 4, to show the global market by regions, with sales, revenue and market share of Vaccine Adjuvants, for each region, from 2012 to 2017;

    Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

    Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

    Chapter 12, Vaccine Adjuvants market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

    Chapter 13, 14 and 15, to describe Vaccine Adjuvants sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source”

  • “Table of Contents

    1 Market Overview
    1.1 Vaccine Adjuvants Introduction
    1.2 Market Analysis by Type
    1.2.1 Oral
    1.2.2 Subcutaneous
    1.2.3 Intramuscular
    1.2.4 Others
    1.3 Market Analysis by Applications
    1.3.1 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
    1.3.2 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
    1.4 Market Analysis by Regions
    1.4.1 North America (USA, Canada and Mexico)
    1.4.1.1 USA Market States and Outlook (2012-2022)
    1.4.1.2 Canada Market States and Outlook (2012-2022)
    1.4.1.3 Mexico Market States and Outlook (2012-2022)
    1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2012-2022)
    1.4.2.2 France Market States and Outlook (2012-2022)
    1.4.2.3 UK Market States and Outlook (2012-2022)
    1.4.2.4 Russia Market States and Outlook (2012-2022)
    1.4.2.5 Italy Market States and Outlook (2012-2022)
    1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2012-2022)
    1.4.3.2 Japan Market States and Outlook (2012-2022)
    1.4.3.3 Korea Market States and Outlook (2012-2022)
    1.4.3.4 India Market States and Outlook (2012-2022)
    1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
    1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2012-2022)
    1.4.4.2 Egypt Market States and Outlook (2012-2022)
    1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
    1.4.4.4 South Africa Market States and Outlook (2012-2022)
    1.4.4.5 Nigeria Market States and Outlook (2012-2022)
    1.5 Market Dynamics
    1.5.1 Market Opportunities
    1.5.2 Market Risk
    1.5.3 Market Driving Force
    2 Manufacturers Profiles
    2.1 SEPPIC
    2.1.1 Business Overview
    2.1.2 Vaccine Adjuvants Type and Applications
    2.1.2.1 Type 1
    2.1.2.2 Type 2
    2.1.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2 SDA BIO
    2.2.1 Business Overview
    2.2.2 Vaccine Adjuvants Type and Applications
    2.2.2.1 Type 1
    2.2.2.2 Type 2
    2.2.3 SDA BIO Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3 Brenntag Biosector
    2.3.1 Business Overview
    2.3.2 Vaccine Adjuvants Type and Applications
    2.3.2.1 Type 1
    2.3.2.2 Type 2
    2.3.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4 SPI Pharma
    2.4.1 Business Overview
    2.4.2 Vaccine Adjuvants Type and Applications
    2.4.2.1 Type 1
    2.4.2.2 Type 2
    2.4.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5 MVP Laboratories
    2.5.1 Business Overview
    2.5.2 Vaccine Adjuvants Type and Applications
    2.5.2.1 Type 1
    2.5.2.2 Type 2
    2.5.3 MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6 Tj Kaiwei
    2.6.1 Business Overview
    2.6.2 Vaccine Adjuvants Type and Applications
    2.6.2.1 Type 1
    2.6.2.2 Type 2
    2.6.3 Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7 Novavax
    2.7.1 Business Overview
    2.7.2 Vaccine Adjuvants Type and Applications
    2.7.2.1 Type 1
    2.7.2.2 Type 2
    2.7.3 Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8 Zhuoyue
    2.8.1 Business Overview
    2.8.2 Vaccine Adjuvants Type and Applications
    2.8.2.1 Type 1
    2.8.2.2 Type 2
    2.8.3 Zhuoyue Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9 Aphios
    2.9.1 Business Overview
    2.9.2 Vaccine Adjuvants Type and Applications
    2.9.2.1 Type 1
    2.9.2.2 Type 2
    2.9.3 Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10 GSK
    2.10.1 Business Overview
    2.10.2 Vaccine Adjuvants Type and Applications
    2.10.2.1 Type 1
    2.10.2.2 Type 2
    2.10.3 GSK Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.11 CSL Limited
    2.11.1 Business Overview
    2.11.2 Vaccine Adjuvants Type and Applications
    2.11.2.1 Type 1
    2.11.2.2 Type 2
    2.11.3 CSL Limited Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.12 Brenntag Biosector
    2.12.1 Business Overview
    2.12.2 Vaccine Adjuvants Type and Applications
    2.12.2.1 Type 1
    2.12.2.2 Type 2
    2.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.13 SEPPIC
    2.13.1 Business Overview
    2.13.2 Vaccine Adjuvants Type and Applications
    2.13.2.1 Type 1
    2.13.2.2 Type 2
    2.13.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.14 SPI Pharma
    2.14.1 Business Overview
    2.14.2 Vaccine Adjuvants Type and Applications
    2.14.2.1 Type 1
    2.14.2.2 Type 2
    2.14.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.15 Novavax
    2.15.1 Business Overview
    2.15.2 Vaccine Adjuvants Type and Applications
    2.15.2.1 Type 1
    2.15.2.2 Type 2
    2.15.3 Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.16 Avanti Polar Lipids
    2.16.1 Business Overview
    2.16.2 Vaccine Adjuvants Type and Applications
    2.16.2.1 Type 1
    2.16.2.2 Type 2
    2.16.3 Avanti Polar Lipids Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.17 Aphios
    2.17.1 Business Overview
    2.17.2 Vaccine Adjuvants Type and Applications
    2.17.2.1 Type 1
    2.17.2.2 Type 2
    2.17.3 Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    3 Global Vaccine Adjuvants Market Competition, by Manufacturer
    3.1 Global Vaccine Adjuvants Sales and Market Share by Manufacturer
    3.2 Global Vaccine Adjuvants Revenue and Market Share by Manufacturer
    3.3 Market Concentration Rate
    3.3.1 Top 3 Vaccine Adjuvants Manufacturer Market Share
    3.3.2 Top 6 Vaccine Adjuvants Manufacturer Market Share
    3.4 Market Competition Trend
    4 Global Vaccine Adjuvants Market Analysis by Regions
    4.1 Global Vaccine Adjuvants Sales, Revenue and Market Share by Regions
    4.1.1 Global Vaccine Adjuvants Sales by Regions (2012-2017)
    4.1.2 Global Vaccine Adjuvants Revenue by Regions (2012-2017)
    4.2 North America Vaccine Adjuvants Sales and Growth (2012-2017)
    4.3 Europe Vaccine Adjuvants Sales and Growth (2012-2017)
    4.4 Asia-Pacific Vaccine Adjuvants Sales and Growth (2012-2017)
    4.5 South America Vaccine Adjuvants Sales and Growth (2012-2017)
    4.6 Middle East and Africa Vaccine Adjuvants Sales and Growth (2012-2017)
    5 North America Vaccine Adjuvants by Countries
    5.1 North America Vaccine Adjuvants Sales, Revenue and Market Share by Countries
    5.1.1 North America Vaccine Adjuvants Sales by Countries (2012-2017)
    5.1.2 North America Vaccine Adjuvants Revenue by Countries (2012-2017)
    5.2 USA Vaccine Adjuvants Sales and Growth (2012-2017)
    5.3 Canada Vaccine Adjuvants Sales and Growth (2012-2017)
    5.4 Mexico Vaccine Adjuvants Sales and Growth (2012-2017)
    6 Europe Vaccine Adjuvants by Countries
    6.1 Europe Vaccine Adjuvants Sales, Revenue and Market Share by Countries
    6.1.1 Europe Vaccine Adjuvants Sales by Countries (2012-2017)
    6.1.2 Europe Vaccine Adjuvants Revenue by Countries (2012-2017)
    6.2 Germany Vaccine Adjuvants Sales and Growth (2012-2017)
    6.3 UK Vaccine Adjuvants Sales and Growth (2012-2017)
    6.4 France Vaccine Adjuvants Sales and Growth (2012-2017)
    6.5 Russia Vaccine Adjuvants Sales and Growth (2012-2017)
    6.6 Italy Vaccine Adjuvants Sales and Growth (2012-2017)
    7 Asia-Pacific Vaccine Adjuvants by Countries
    7.1 Asia-Pacific Vaccine Adjuvants Sales, Revenue and Market Share by Countries
    7.1.1 Asia-Pacific Vaccine Adjuvants Sales by Countries (2012-2017)
    7.1.2 Asia-Pacific Vaccine Adjuvants Revenue by Countries (2012-2017)
    7.2 China Vaccine Adjuvants Sales and Growth (2012-2017)
    7.3 Japan Vaccine Adjuvants Sales and Growth (2012-2017)
    7.4 Korea Vaccine Adjuvants Sales and Growth (2012-2017)
    7.5 India Vaccine Adjuvants Sales and Growth (2012-2017)
    7.6 Southeast Asia Vaccine Adjuvants Sales and Growth (2012-2017)
    8 South America Vaccine Adjuvants by Countries
    8.1 South America Vaccine Adjuvants Sales, Revenue and Market Share by Countries
    8.1.1 South America Vaccine Adjuvants Sales by Countries (2012-2017)
    8.1.2 South America Vaccine Adjuvants Revenue by Countries (2012-2017)
    8.2 Brazil Vaccine Adjuvants Sales and Growth (2012-2017)
    8.3 Argentina Vaccine Adjuvants Sales and Growth (2012-2017)
    8.4 Columbia Vaccine Adjuvants Sales and Growth (2012-2017)
    9 Middle East and Africa Vaccine Adjuvants by Countries
    9.1 Middle East and Africa Vaccine Adjuvants Sales, Revenue and Market Share by Countries
    9.1.1 Middle East and Africa Vaccine Adjuvants Sales by Countries (2012-2017)
    9.1.2 Middle East and Africa Vaccine Adjuvants Revenue by Countries (2012-2017)
    9.2 Saudi Arabia Vaccine Adjuvants Sales and Growth (2012-2017)
    9.3 UAE Vaccine Adjuvants Sales and Growth (2012-2017)
    9.4 Egypt Vaccine Adjuvants Sales and Growth (2012-2017)
    9.5 Nigeria Vaccine Adjuvants Sales and Growth (2012-2017)
    9.6 South Africa Vaccine Adjuvants Sales and Growth (2012-2017)
    10 Global Vaccine Adjuvants Market Segment by Type
    10.1 Global Vaccine Adjuvants Sales, Revenue and Market Share by Type (2012-2017)
    10.1.1 Global Vaccine Adjuvants Sales and Market Share by Type (2012-2017)
    10.1.2 Global Vaccine Adjuvants Revenue and Market Share by Type (2012-2017)
    10.2 Oral Sales Growth and Price
    10.2.1 Global Oral Sales Growth (2012-2017)
    10.2.2 Global Oral Price (2012-2017)
    10.3 Subcutaneous Sales Growth and Price
    10.3.1 Global Subcutaneous Sales Growth (2012-2017)
    10.3.2 Global Subcutaneous Price (2012-2017)
    10.4 Intramuscular Sales Growth and Price
    10.4.1 Global Intramuscular Sales Growth (2012-2017)
    10.4.2 Global Intramuscular Price (2012-2017)
    10.5 Others Sales Growth and Price
    10.5.1 Global Others Sales Growth (2012-2017)
    10.5.2 Global Others Price (2012-2017)
    11 Global Vaccine Adjuvants Market Segment by Application
    11.1 Global Vaccine Adjuvants Sales Market Share by Application (2012-2017)
    11.2 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2012-2017)
    11.3 Human Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2012-2017)
    12 Vaccine Adjuvants Market Forecast (2017-2022)
    12.1 Global Vaccine Adjuvants Sales, Revenue and Growth Rate (2017-2022)
    12.2 Vaccine Adjuvants Market Forecast by Regions (2017-2022)
    12.2.1 North America Vaccine Adjuvants Market Forecast (2017-2022)
    12.2.2 Europe Vaccine Adjuvants Market Forecast (2017-2022)
    12.2.3 Asia-Pacific Vaccine Adjuvants Market Forecast (2017-2022)
    12.2.4 South America Vaccine Adjuvants Market Forecast (2017-2022)
    12.2.5 Middle East and Africa Vaccine Adjuvants Market Forecast (2017-2022)
    12.3 Vaccine Adjuvants Market Forecast by Type (2017-2022)
    12.4 Vaccine Adjuvants Market Forecast by Application (2017-2022)
    13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
    13.1.1 Direct Marketing
    13.1.2 Indirect Marketing
    13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
    14 Research Findings and Conclusion
    15 Appendix
    15.1 Methodology
    15.2 Analyst Introduction
    15.3 Data Source”

  • Inquiry Before Buying

  • Request For Sample